NCT01184391View on ClinicalTrials.gov

Bioequivalence Study of Divalproex Sodium Delayed-Release Tablets, 500 mg

PHASE1CompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

July 31, 2007

Primary Completion Date

August 31, 2007

Study Completion Date

August 31, 2007

Conditions
Healthy
Interventions
DRUG

DEPAKOTE® Tablets, 500 MG

1 x 500 mg tablet, under fasting conditions

DRUG

DIVALPROEX SODIUM DELAYED-RELEASE TABLETS, USP, 500 MG

1 X 500 mg Tablet, under fasting conditions.

Trial Locations (1)

26505

Kendle International Inc., Morgantown

Sponsors
All Listed Sponsors
lead

Mylan Pharmaceuticals Inc

INDUSTRY